Eye complications of cetuximab therapy

European Journal of Cancer Care

Volumn 16, Issue 5, 2007, Pages 439-443

  Melichar, B ^a   Nemcova I ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Blepharitis; Cetuximab; Colon cancer; Conjunctivitis; Therapy; Trichomegaly

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; COLORECTAL TUMOR; DRUG ERUPTION; EYE DISEASE; FEMALE; HUMAN; MALE; METASTASIS; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DRUG ERUPTIONS; EYE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; TREATMENT OUTCOME;

EID: 34548357272     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2006.00763.x     Document Type: Article

References (17)

1. Almagro M., del Pozo J., Garcia-Silva J., Martinez W., Castro A. Fonseca E. (2003) Eyelash length in HIV-infected patients. AIDS 17, 1695 1696.
2. Bouche O., Brixi-Benmansour H., Bertin A., Perceau G. Lagarde S. (2005) Trichomegaly of the eyelashes following treatment with cetuximab. Annals of Oncology 16, 1711 1712.
3. Busam K.J., Capodieci P., Motzer R., Kiehn T., Phelan D. Halpern A.C. (2001) Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225. British Journal of Dermatology 144, 1169 1176.
4. Cunningham D., Hurnblet Y., Siena S., Khayat D., Bleiberg H., Santoro A., Bets D., Mueser M., Harstrick A., Verslype C., Chau I. Van Cutsem E. (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. New England Journal of Medicine 351, 337 345.
5. Delaney Y.M., Salmon J.F., Mossa F., Gee B., Beehne K. Powell S. (2002) Periorbital dermatitis as a side effect of topical dorzolamide. British Journal of Ophthalmology 86, 378 380.
6. Dueland S., Sauer T., Lund-Johansen F., Ostenstad B. Tveit K.M. (2003) Epidermal growth factor receptor inhibition induces trichomegaly. Acta Oncologica 42, 345 346.
7. Guin J.D. (2002) Eyelid dermatitis: experience in 203 cases. Journal of American Academy of Dermatology 47, 755 765.
8. Haritoglou C., Rudolph G., Kalpadakis P. Boergen K.P. (2003) Congenital trichomegaly (Oliver-McFarlane syndrome): a case report with 9 years' follow up. British Journal of Ophthalmology 87, 119 120.
9. Herbst R.A., Uter W., Pirker C., Geier J. Frosch P.J. (2004) Allergic and non-allergic periorbital dermatitis: patch test results of the information network of the departments of dermatology during a 5-year period. Contact Dermatitis 51, 13 19.
10. Hernandez-Nunez A., Fernandez-Herrera J., Buceta L.R. Garcia-Diez A. (2002) Trichomegaly following treatment with interferon alpha-2b. Lancet 359, 1107.
11. Huber-Spitzy V., Baumgartner I., Böhler-Sommeregger K. Grabner G. (1991) Blepharitis - a diagnostic and therapeutic challenge. Graefe's Archive for Clinical and Experimental Ophthalmology 229, 224 227.
12. McCulley J.P. Shine W.E. (2000) Changing concepts in the diagnosis and management of blepharitis. Cornea 19, 650 658.
13. Moss J.E. Burtness B. (2005) Cetuximab-associated acneiform eruption. New England Journal of Medicine 353, e17.
14. Segaert S. Van Cutsem E. (2005) Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Annals of Oncology 16, 1425 1433.
15. Segaert S., Tabernero J., Chosidov O., Dirschka T., Elsner J., Mancini L., Maughan T., Morere J.F., Santoro A., Sobrero A., Van Cutsem E. Layton A. (2005) Management of skin reaction in cancer patients receiving epidermal growth factor receptor targeted therapies. Journal der Deutschen Dermatologischen Gesellschaft 3, 599 606.
16. Wollenberg A., Kerschenlohr K., Pavicic T. Messmer E.M. (2004) Diagnostik und Therapie des Lidekzems. Eine interdisziplinäre Herauforderung. Hautarzt 55, 677 688.
17. Youn S.W., Na J.I., Choi S.Y., Huh C.H. Park K.C. (2005) Regional and seasonal variations in facial sebum secretions: a proposal for the definition of combination skin type. Skin Research and Technology 11, 189 195.